Stock Price Quote

HALEOS LABS LTD.

NSE : HALEOSLABSBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE1206.05-62.95 (-4.96 %)
PREV CLOSE ( ) 1269.00
OPEN PRICE ( ) 1206.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50
TODAY'S LOW / HIGH ( )1206.05 1206.05
52 WK LOW / HIGH ( )956.05 1680
NSE1234.60-18.1 (-1.44 %)
PREV CLOSE( ) 1252.70
OPEN PRICE ( ) 1201.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 223
TODAY'S LOW / HIGH( ) 1201.20 1260.00
52 WK LOW / HIGH ( )959.8 1680
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-05 2006
Management Info
- Chairman TVVSN Murthy - Managing Director
Registered Office

Address Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040-66288888

Email info@smslife.in

Website www.smslife.in

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE

NEWS

21Jan Haleos Labs enters into strategic Deve
Haleos Labs has entered into strategic Development collaboration with HR..
21Jan Haleos Labs informs about collaboratio
Haleos Labs has informed that the Company has entered into strategic Dev..
10Nov SMS Lifesciences India informs about o
SMS Lifesciences India has informed that the Board of Directors of the C..
14Oct Haleos Labs informs about certificate
Haleos Labs has informed that it enclosed the Certificate received from..
20Sep SMS Lifesciences India informs about c
SMS Lifesciences India has informed that Trading Window for dealing in s..

Financials

in Millions
QTR Sep 25 ANNUAL 25
Net Profit49.78213.7
Gross Profit 70.48 300.4
Operating Profit 112.36481.77
Net Sales 778.443333.71

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  27604.70 (1.43%)
M.Cap ( in Cr)58658.06
Senores Pharmaceutic (BSE)
peergroup  834.80 (6.60%)
M.Cap ( in Cr)3844.55
Aarti Pharmalabs (BSE)
peergroup  794.40 (5.55%)
M.Cap ( in Cr)7201.02
Sanofi Cons. Health (BSE)
peergroup  4084.90 (0.97%)
M.Cap ( in Cr)9407.78
Ajanta Pharma (BSE)
peergroup  2714.30 (1.13%)
M.Cap ( in Cr)33911.28

Shareholding Pattern

PROMOTERS 71.8%
NON-INSTITUTION 27.91%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Haleos Labs Ltd.

Haleos Labs Ltd. was incorporated in the year 2006. Its today's share price is 1206.05. Its current market capitalisation stands at Rs 364.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3683.55 Cr and Total Income of Rs.3373.17 Cr. The company's management includes Trupti Ranjan Mohanty, Sundaramma Patibandla, Srinivas Samavedam, Mannam Malakondaiah, P Sarath Kumar, Sudeepthi Gopineedi, T V Praveen, TVVSN Murthy.

It is listed on the BSE with a BSE Code of 540679 , NSE with an NSE Symbol of HALEOSLABS and ISIN of INE320X01016. It's Registered office is at Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee HillsHyderabad-500096, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Rambabu & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.